Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
A new Medicare policy may have improved access to methadone and buprenorphine treatment for Medicare beneficiaries with a diagnosed opioid use disorder (OUD) during the COVID-19 pandemic, but further research is needed to determine its impact.